Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.


Investor type Private Equity Firm
Founders Christoph Kausch Felix Grisard Hans Florian Zeilhofer


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 16
Average round size
The average size of a deal this fund participated in
Portfolio companies 13
Rounds per year 2.00
Lead investments 4
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees 1
Stages of investment
Private Equity

Areas of investment

  • Health Care
  • Medical Device
  • Artificial Intelligence
  • Hospital
  • Medical

In 2014 was created MTIP AG, which is appeared as VC. The venture was found in Europe in Switzerland. The main office of represented VC is situated in the Basel.

Among the most popular fund investment industries, there are Biotechnology, Robotics. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Lumeon, TytoCare, Cynerio. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Israel.

The important activity for fund was in 2018. The fund is generally included in 2-6 deals every year. Speaking about the real fund results, this VC is 23 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars.

The fund was created by Christoph Kausch, Felix Grisard, Hans Florian Zeilhofer.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the MTIP AG, startups are often financed by Walgreens, Teuza, OrbiMed. The meaningful sponsors for the fund in investment in the same round are High-Tech Gru00fcnderfonds, Bayern Kapital GmbH, Walgreens. In the next rounds fund is usually obtained by TechWald Holding S.p.A., Shenzhen Capital Group, Sanford Health.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of MTIP AG:
Typical Co-investors
MTIP AG is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after MTIP AG:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Switzerland
Funds with similar focus located in Switzerland:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Artificial Intelligence
Health Care
$20M05 Aug 2022 Paris, Ile-de-France, France


Artificial Intelligence
Health Care
$23M21 Jun 2022 Leuven, Flemish Brabant, Belgium


Artificial Intelligence
Health Care
Machine Learning
$12M04 Oct 2021 Barcelona, Catalonia, Spain


Health Care
Personal Health
$94M31 Aug 2021 London, England, United Kingdom


Artificial Intelligence
Big Data
Clinical Trials
Enterprise Software
Health Care
Life Science
Machine Learning
$12M10 Aug 2021 New York, New York, United States


Cyber Security
Health Care
Information Technology
Medical Device
Network Security
$30M19 May 2021 New York, New York, United States

Koa Health

Health Care
Medical Device
Natural Language Processing
$35M09 Feb 2021 Catalonia


Health Care
$30M11 Aug 2020 London, England, United Kingdom


Enterprise Software
$12M28 Apr 2020 Skåne County
Intelligencia Raises $12M to Reduce the Risk of Clinical Research, Improve R&D Productivity, and Accelerate Scientific Breakthroughs

– Intelligencia, whose AI-driven software platform enables pharmaceutical and biotechnology companies to revolutionize the drug development process and reduce risk, has raised $12M in order to continue to expand its product offering and customer base.
– Healthtech investor MTIP led the oversubscribed Series A round, joined by several of the company’s existing investors, including Big Pi Ventures and Synetro Group. ZS, a global professional services firm that leverages deep analytics and biopharmaceutical industry expertise to help companies and their customers thrive, has also participated in this round.
– The company’s founders, Dimitrios Skaltsas and Vangelis Vergetis, met while at McKinsey & Company, and have spent more than a decade in the intersection of clinical development, data science, and technology solutions.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent MTIP AG?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: